Experts provided an in-depth review of Janus kinase (JAK) inhibitors, discussing the latest research on their use in the treatment of specific rheumatic conditions, the risks associated with them and more.

Experts provided an in-depth review of Janus kinase (JAK) inhibitors, discussing the latest research on their use in the treatment of specific rheumatic conditions, the risks associated with them and more.
Matteo Piga, MD, highlighted the latest research into Behçet’s disease, including developments into the understanding of its pathophysiology and positive results for potential treatments.
New ICD-10-CM code R76.81 can now be used for patients who have abnormal rheumatoid arthritis (RA)-related autoantibodies—but not RA—to improve early disease risk identification, preventive care and research.
The proposed rule includes several proposals related to Medicare physician payment and the Quality Payment Program. Read more about the provisions the ACR will address during the comment period.
August offers an opportunity to engage with your elected officials in your state or district. Lawmakers will be considering appropriations bills when they return in September—help make sure the needs of the rheumatology community are top of mind.
The inaugural event, to be held before ACR Convergence, will offer actionable strategies and expert insights to build a smarter, stronger and more financially sustainable practice in today’s rapidly evolving healthcare landscape.
In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes.
CPPD is notoriously difficult to diagnose due to its diverse presentations & uncertain etiology. Recent advances have helped rheumatologists better understand its risk factors, classify, diagnose & treat the condition.
Clark Kent, Hannah Montana, Dexter Morgan, David Bowie and your friendly neighborhood rheumatologist: What do all of these people have in common? Chances are, they…